FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

4573111000001109: Lidocaine 4% oromucosal solution 4ml vials 25 vial (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21311301000001110 Lidocaine 4% oromucosal solution 4ml vials 25 vial (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
44859101000001113 Lidocaine 160mg/4ml (4%) oromucosal solution pre-filled syringes 25 pre-filled disposable injection en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lidocaine 4% oromucosal solution 4ml vials 25 vial Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lidocaine 4% oromucosal solution 4ml vials 25 vial Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Lidocaine 4% oromucosal solution 4ml vials 25 vial Is pack of Lidocaine hydrochloride 40mg/mL(4%) sterile solution false Inferred relationship Existential restriction modifier
Lidocaine 4% oromucosal solution 4ml vials 25 vial Has active ingredient Lidocaine hydrochloride false Inferred relationship Existential restriction modifier
Lidocaine 4% oromucosal solution 4ml vials 25 vial Has active ingredient Lidocaine false Inferred relationship Existential restriction modifier
Lidocaine 4% oromucosal solution 4ml vials 25 vial VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lidocaine 4% oromucosal solution 4ml vials 25 vial VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Lidocaine 4% oromucosal solution 4ml vials 25 vial Has manufactured dose form Basic dose form with liquid state of matter false Inferred relationship Existential restriction modifier
Lidocaine 4% oromucosal solution 4ml vials 25 vial Has VMP Lidocaine hydrochloride 40mg/mL(4%) sterile solution false Inferred relationship Existential restriction modifier
Lidocaine 4% oromucosal solution 4ml vials 25 vial Has specific active ingredient Lidocaine hydrochloride true Inferred relationship Existential restriction modifier
Lidocaine 4% oromucosal solution 4ml vials 25 vial Has dispensed dose form Basic dose form with liquid state of matter true Inferred relationship Existential restriction modifier
Lidocaine 4% oromucosal solution 4ml vials 25 vial Has VMP Lidocaine 160mg/4ml (4%) oromucosal solution pre-filled syringes false Inferred relationship Existential restriction modifier
Lidocaine 4% oromucosal solution 4ml vials 25 vial VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Lidocaine 4% oromucosal solution 4ml vials 25 vial Has VMP Lidocaine 160mg/4ml (4%) oromucosal solution pre-filled syringes true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Laryng-O-Jet 4% oromucosal solution 4ml vials (Celltech Pharmaceuticals Ltd) 25 vial 25 x 4ml vials Is a True Lidocaine 4% oromucosal solution 4ml vials 25 vial Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start